TY - JOUR
T1 - Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin kappa/lambda Ratios
AU - Bradwell, Arthur
AU - Harding, SJ
AU - Fourrier, NJ
AU - Wallis, GLF
AU - Drayson, Mark
AU - Carr-Smith, HD
AU - Mead, Graham
PY - 2009/9/1
Y1 - 2009/9/1
N2 - BACKGROUND: Currently, monoclonal immunoglobulins are identified and quantified from bands on electrophoretic gels. As an alternative, clonality might be determined by measuring the separate light chain types of each Ig class to allow numerical assessment of Ig'kappa/Ig'lambda ratios, analogous to free light chain kappa/lambda ratios.
METHODS: Using immunization, tolerization, and adsorption procedures, we prepared sheep antibodies against each of the 6 separate molecules, IgG kappa, IgG lambda, IgA kappa, IgA lambda, IgM kappa, and IgM lambda. Antibody targets comprised the junctional epitopes between the heavy chain and light chain domains. After purification, we assessed the antisera on a Siemens Dade-Behring BN (TM) II nephelometer for analytical quality and clinical utility.
RESULTS: High-avidity, specific antibodies allowed the production of automated nephelometric immunoassays for each Ig light chain type. Laboratory comparison with serum protein electrophoresis, using dilution experiments, showed lower analytical sensitivity for monoclonal IgG detection but similar or greater sensitivity for IgA and IgM, particularly when the monoclonal bands overlaid transferrin. Results obtained from typing of monoclonal proteins into IgG, A, or M types were comparable with results obtained by immunofixation-electrophoresis methods. Initial clinical studies, in multiple myeloma patients, indicated that Ig'kappa/Ig'lambda ratios were sometimes more sensitive than immunofixation electrophoresis, provided numerical results, and correlated with changes in disease.
CONCLUSIONS: Immunoassays for intact Ig kappa/lambda pairs are possible and should assist in the management of patients with monoclonal gammopathies. (C) 2009 American Association for Clinical Chemistry
AB - BACKGROUND: Currently, monoclonal immunoglobulins are identified and quantified from bands on electrophoretic gels. As an alternative, clonality might be determined by measuring the separate light chain types of each Ig class to allow numerical assessment of Ig'kappa/Ig'lambda ratios, analogous to free light chain kappa/lambda ratios.
METHODS: Using immunization, tolerization, and adsorption procedures, we prepared sheep antibodies against each of the 6 separate molecules, IgG kappa, IgG lambda, IgA kappa, IgA lambda, IgM kappa, and IgM lambda. Antibody targets comprised the junctional epitopes between the heavy chain and light chain domains. After purification, we assessed the antisera on a Siemens Dade-Behring BN (TM) II nephelometer for analytical quality and clinical utility.
RESULTS: High-avidity, specific antibodies allowed the production of automated nephelometric immunoassays for each Ig light chain type. Laboratory comparison with serum protein electrophoresis, using dilution experiments, showed lower analytical sensitivity for monoclonal IgG detection but similar or greater sensitivity for IgA and IgM, particularly when the monoclonal bands overlaid transferrin. Results obtained from typing of monoclonal proteins into IgG, A, or M types were comparable with results obtained by immunofixation-electrophoresis methods. Initial clinical studies, in multiple myeloma patients, indicated that Ig'kappa/Ig'lambda ratios were sometimes more sensitive than immunofixation electrophoresis, provided numerical results, and correlated with changes in disease.
CONCLUSIONS: Immunoassays for intact Ig kappa/lambda pairs are possible and should assist in the management of patients with monoclonal gammopathies. (C) 2009 American Association for Clinical Chemistry
U2 - 10.1373/clinchem.2009.123828
DO - 10.1373/clinchem.2009.123828
M3 - Article
C2 - 19617289
VL - 55
SP - 1646
EP - 1655
JO - Clinical Chemistry
JF - Clinical Chemistry
IS - 9
ER -